Slow Tapering of Semaglutide Maintains Weight Loss: New Study Insights
Personalized Dosing and Digital Programs Key to Long-Term Success
Topline: A recent study highlights the effectiveness of personalized dosing and gradual tapering of semaglutide (Wegovy or Ozempic) in conjunction with a digital weight loss program. This approach achieves significant weight loss and maintains it for up to six months, offering promising implications for both patients and healthcare providers.
Study Detai…



